Oura Inc. IPO Preview: Fast Growth Meets Subscription Retention
Oura Inc. is expected to list on NASDAQ on 2026-09-30 under ticker OURA, with shares priced at $40.00 to $44.00. The deal centers on a fast-growing smart-ring business with a sticky subscription model, but investors will need to weigh concentration, competition, and how much growth can hold after the IPO.
Oura Inc. is expected to list on NASDAQ on 2026-09-30 under ticker OURA, with shares priced at $40.00 to $44.00. The deal centers on a fast-growing smart-ring business with a sticky subscription model, but investors will need to weigh concentration, competition, and how much growth can hold after the IPO.
Quick Facts
Expected listing date: September 30, 2026
Exchange: NASDAQ
Proposed symbol: OURA
Price range: 40.00 - 44.00
Shares offered: 50.00M shares
Implied market cap: $2.53B
Status: Expected
Company Overview
Oura sells the Oura Ring smart ring and a paid subscription called Oura Membership. The company makes money in two ways: hardware sales through direct-to-consumer and wholesale channels, including retail and enterprise partners, and recurring membership revenue that unlocks additional app features and functionality. Oura describes itself as a personal health system built on longitudinal biometric data from the ring and third-party integrations.
The business was founded in Finland in 2013 and redomiciled to the U.S. on March 31, 2026, with Oura Inc. now the Delaware parent. The company lists its business address in San Francisco and says it has offices in Oulu, Helsinki, San Francisco, San Diego, and Los Angeles. It is competing in a crowded wearables market against Apple, Garmin, Fitbit/Google, WHOOP, and others, while framing its opportunity around proactive health management, AI-enabled insights, and a broader preventative-health spend opportunity it pegs at over $90 billion. Oura also says global wearable shipments totaled about 212 million units in the 12 months ended June 30, 2026, and that it represented about 2% of that market.
Why They're Going Public
Oura says the primary use of proceeds from the offering is to fund tax withholding and remittance obligations tied to RSU net settlement, which it estimates at about $526.4 million of the expected net proceeds. Any remainder is slated for general corporate purposes, including technology development, working capital, operating expenses, and capital expenditures.
The IPO also gives Oura a public currency for future growth. The filing says the company may use some proceeds for acquisitions or investments, though it has no material commitments. With strategic interest already signaled by Eli Lilly and Dragoneer, the listing also helps formalize the company’s capital structure as it scales its hardware-plus-subscription model.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Oura’s top line has accelerated sharply. Revenue rose to $907.9 million in fiscal 2025 from $406.8 million in fiscal 2024, a 123% increase. For the nine months ended June 30, 2026, revenue reached $1.2145 billion, up 74% from $697.6 million in the prior-year period. Membership revenue was a major driver, climbing from $108.8 million to $240.5 million in that nine-month period, up 121% year over year.
Profitability has improved, though the company is still early in its earnings story. Net income was $0.01 million in fiscal 2025 versus $3.6 million in fiscal 2024, while the nine months ended June 30, 2026 produced net income of $60.8 million versus $1.6 million a year earlier. Gross margin was 52% in fiscal 2025 and 55% for the nine-month period. As of June 30, 2026, Oura had $371.8 million of cash and cash equivalents and $380.1 million of total debt outstanding, including $375.0 million drawn on its revolving credit facility.
Risk Factors
The biggest risk is whether Oura can keep growing at this pace. The filing explicitly warns that rapid growth may not be sustainable, and substantially all revenue comes from just two products: the Oura Ring and Oura Membership. That makes the story attractive if the category keeps expanding, but vulnerable if demand cools or if the product cycle slips.
Competition is another major issue. Oura is up against much larger consumer technology and health brands with deeper resources and stronger recognition, and the filing also points to supply-chain and manufacturing risk, including component shortages, quality issues, and supplier disruptions. Tariffs and trade barriers could pressure gross margin, and litigation-related expenses plus IPO preparation costs have already lifted G&A. Investors should also watch the large share count and the fact that selling stockholders are offering 36.5 million shares alongside the 13.5 million primary shares, which can weigh on near-term trading dynamics.
Comparable Public Companies
The closest public comps are Garmin (GRMN), Apple (AAPL), Alphabet (GOOGL), and DexCom (DXCM). Garmin is the cleanest listed wearables comparison because it sells connected devices into fitness and health, while Apple and Alphabet matter because they anchor the broader consumer-device and health-data ecosystems. DexCom is not a direct wearables peer, but it is useful for thinking about health-data platforms and recurring engagement. In a looser consumer subscription-hardware frame, some investors may also look at Peloton (PTON), though that is a less direct comparison.
The comp set is mixed rather than uniformly hot. Apple and Alphabet trade as mega-cap platform names, Garmin tends to be valued more like a mature hardware company with recurring software elements, and DexCom usually commands a premium tied to medical-device growth and recurring usage. Without using live market data, the broad read is that this is not a single clean multiple bucket: the market is likely to compare Oura’s growth and subscription retention against hardware cyclicality and the durability of its margin profile. That makes the IPO story more about category quality and retention than about a simple peer-multiple screen.
Verdict
The setup favors a growth story with real subscription stickiness, but the key question as Oura prices is how much of the recent surge is durable. The company has strong revenue momentum, a high conversion rate from ring activations to paid members at over 94%, and nearly all paid members are monthly active users. At the same time, the deal is large, the float is meaningful, and the company is still concentrated in one product ecosystem, so investors should watch how the market balances growth against execution risk.
This IPO lands in a market that still rewards clear secular narratives, and Oura has one: wearables tied to proactive health and AI-driven personalization. That makes it noteworthy right now because it sits at the intersection of consumer hardware, recurring revenue, and preventative health. The main watch item is whether pricing reflects that narrative without assuming growth stays near recent levels once the company is public.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
